How fast will I lose weight on GLP-1s and is it sustainable?

Short answer

• Many people lose substantial weight on GLP‑1s, often in the first 3–12 months. Typical clinical-trial averages are roughly:
  • Semaglutide (Wegovy/Ozempic): about 10–15% body weight loss over ~6–12 months (Wegovy is the FDA‑approved weight‑loss product; Ozempic is for diabetes but is sometimes used off‑label).
  • Tirzepatide (Zepbound/Mounjaro): often larger losses — many trials showed ~15–20% (and up to ~20%+) at 6–12+ months for higher doses (Zepbound is FDA‑approved for chronic weight management; Mounjaro is approved for diabetes and used off‑label by some clinicians).
• Rate varies a lot. Some people lose several pounds per week early on; others lose more slowly. Expect most of the medication’s effect in the first 6–12 months if you stay on the drug.

Is it sustainable?

• GLP‑1s work by lowering appetite and altering appetite signals. While you take them, many people maintain lower weight.
• Stopping a GLP‑1 commonly leads to partial or full regain unless you’ve made durable lifestyle/behavioral changes or use another maintenance strategy. Clinical studies show weight tends to come back after discontinuation for many people.
• Long‑term maintenance often requires one or more of: continuing medication, structured behavioral therapy, permanent diet/exercise/behavior changes, and medical follow‑up.

Things to consider

• Individual results vary by starting weight, dose, adherence, diet/exercise, genetics, and other meds/conditions.
• Side effects are common (nausea, diarrhea, constipation, abdominal pain) and usually improve over weeks; rare but serious risks (pancreatitis, gallbladder disease, certain thyroid concerns) should be discussed with a clinician.
• Cost and insurance coverage vary widely; some GLP‑1s are expensive and may not be covered for weight management.

Practical next steps

1. See a clinician (primary care, endocrinologist, or obesity medicine doctor) to discuss goals, screen for contraindications, and get baseline labs.
2. Plan for lifestyle support (dietitian, health coach, behavior therapy, exercise program) alongside medication.
3. Talk about a realistic timeline and a plan for maintenance or tapering if your goal is to stop medication later.

Brands/services you can consider (and why)

• Wegovy (semaglutide 2.4 mg) — FDA‑approved specifically for chronic weight management; strong clinical-trial evidence for ~10–15% weight loss.
• Zepbound / Mounjaro (tirzepatide) — tirzepatide showed larger average weight loss in trials; Zepbound is the brand approved for weight management, while Mounjaro (same active drug) is approved for diabetes and sometimes used off‑label.
• Ozempic / Rybelsus (semaglutide — injectable and oral) — Ozempic is for diabetes but used off‑label for weight loss; Rybelsus is an oral semaglutide option (lower doses used for diabetes; weight‑loss dosing differs).
• Telehealth services: Hims & Hers, Ro (Roman), and One Medical — convenient telemedicine evaluation and prescription options; useful if you need easy access and follow‑up, but be sure they provide lab monitoring and ongoing support.
• Specialist clinics: local obesity medicine clinics or ABOM‑certified (American Board of Obesity Medicine) physicians — best for personalized long‑term plans, complex medical histories, and coordinated care.

If you’d like, tell me:

• your current weight/height or percent weight‑loss goal,
• any medical conditions or medications, and I can give a more tailored expectation, pros/cons of specific drugs, and questions to ask a prescriber.